Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study.
Lammers SWM, Meegdes M, Vriens IJH, Voogd AC, de Munck L, van Nijnatten TJA, Keymeulen KBMI, Tjan-Heijnen VCG, Geurts SME. Lammers SWM, et al. Among authors: vriens ijh. ESMO Open. 2024 Apr 26;9(5):103008. doi: 10.1016/j.esmoop.2024.103008. Online ahead of print. ESMO Open. 2024. PMID: 38677006 Free PMC article.
Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study.
Ter Welle-Butalid ME, van Osch L, van Bree BE, Vriens IJH, Derhaag JG, de Die-Smulders CEM, Tjan-Heijnen VCG, van Golde RJT. Ter Welle-Butalid ME, et al. Among authors: vriens ijh. Eur J Obstet Gynecol Reprod Biol. 2024 Feb;293:27-31. doi: 10.1016/j.ejogrb.2023.12.009. Epub 2023 Dec 9. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38100938 Free article.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM, Geurts SME, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT, Smidt ML, Vriens IJH, Tjan-Heijnen VCG. Lammers SWM, et al. Among authors: vriens ijh. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad092. doi: 10.1093/jncics/pkad092. JNCI Cancer Spectr. 2023. PMID: 37991939 Free PMC article. Clinical Trial.
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Lammers SWM, Thurisch H, Vriens IJH, Meegdes M, Engelen SME, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Peters NAJB, Tol J, Heijns JB, van de Wouw AJ, Teeuwen NJA, Geurts SME, Tjan-Heijnen VCG. Lammers SWM, et al. Among authors: vriens ijh. Breast Cancer Res Treat. 2024 Jan;203(2):339-349. doi: 10.1007/s10549-023-07108-6. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878148 Free PMC article.
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
Tjan-Heijnen VCG, Lammers SWM, Geurts SME, Vriens IJH, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT; Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators. Tjan-Heijnen VCG, et al. Among authors: vriens ijh. EClinicalMedicine. 2023 Mar 20;58:101901. doi: 10.1016/j.eclinm.2023.101901. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 36992863 Free PMC article.
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
Ibragimova KIE, Geurts SME, Meegdes M, Erdkamp F, Heijns JB, Tol J, Vriens BEPJ, Dercksen MW, Aaldering KNA, Pepels MJAE, van de Winkel L, Peters NAJB, Teeuwen-Dedroog NJA, Vriens IJH, Tjan-Heijnen VCG. Ibragimova KIE, et al. Among authors: vriens ijh. Breast Cancer Res Treat. 2023 Apr;198(2):239-251. doi: 10.1007/s10549-022-06832-9. Epub 2023 Jan 12. Breast Cancer Res Treat. 2023. PMID: 36635428 Free PMC article.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, Dercksen MW, Vriens BEPJ, Aaldering KNA, Pepels MJAE, van de Winkel LMH, Tol J, Heijns JB, van de Wouw AJ, Peters NAJB, Hochstenbach-Waelen A, Smidt ML, Geurts SME, Tjan-Heijnen VCG. Meegdes M, et al. Among authors: vriens ijh. Breast Cancer Res Treat. 2022 Apr;192(2):331-342. doi: 10.1007/s10549-021-06472-5. Epub 2022 Jan 13. Breast Cancer Res Treat. 2022. PMID: 35025003 Free PMC article.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Ibragimova KIE, Geurts SME, Croes S, Erdkamp F, Heijns JB, Tol J, Vriens BEPJ, Aaldering KNA, Dercksen MW, Pepels MJAE, Peters NAJB, van de Winkel L, Tilli DJP, Vriens IJH, de Boer M, Tjan-Heijnen VCG. Ibragimova KIE, et al. Among authors: vriens ijh. Breast Cancer Res Treat. 2021 Jul;188(2):571-581. doi: 10.1007/s10549-021-06178-8. Epub 2021 Mar 20. Breast Cancer Res Treat. 2021. PMID: 33743103 Free PMC article.
Unraveling the Heterogeneity of Sarcoma Survivors' Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study.
van Eck I, den Hollander D, Desar IME, Soomers VLMN, van de Sande MAJ, de Haan JJ, Verhoef C, Vriens IJH, Bonenkamp JJ, van der Graaf WTA, van Houdt WJ, Husson O. van Eck I, et al. Among authors: vriens ijh. Cancers (Basel). 2020 Oct 22;12(11):3083. doi: 10.3390/cancers12113083. Cancers (Basel). 2020. PMID: 33105807 Free PMC article.
20 results